Drug application
SEVELAMER CARBONATE (SEVELAMER CARBONATE)
Drugs@FDA ANDA 206234 · INVAGEN PHARMS
Key facts
| Drug name | SEVELAMER CARBONATE |
|---|---|
| Active ingredients | SEVELAMER CARBONATE |
| Application type | ANDA |
| Application number | 206234 |
| Company | INVAGEN PHARMS |
| Dosage forms | FOR SUSPENSION, ORAL |
| Strength | 800MG/PACKET |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Jul 12, 2024 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.